Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:933-939

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbaro, G.
Right arrow Articles by Barbarini, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbaro, G.
Right arrow Articles by Barbarini, G.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Congestive
Right arrow Infectious endocarditis
Right arrow Myocardial cardiomyopathy disease

(Circulation. 1999;100:933-939.)
© 1999 American Heart Association, Inc.


Clinical Investigation and Reports

Intensity of Myocardial Expression of Inducible Nitric Oxide Synthase Influences the Clinical Course of Human Immunodeficiency Virus-Associated Cardiomyopathy

Giuseppe Barbaro, MD; Gabriella Di Lorenzo, MD; Maurizio Soldini, MD; Giuseppe Giancaspro, MD; Benvenuto Grisorio, MD; Adriano Pellicelli, MD; Giorgio Barbarini, MD; for the Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA)1

From the Department of Emergency Medicine, University La Sapienza, Rome (G. Barbaro, G.D.L., M.S., G.G.); the Division of Infectious Diseases, General Hospital, Foggia (B.G.); the 2nd Division of Infectious Diseases, Spallanzani Hospital, Rome (A.P.); and the Department of Infectious and Tropical Diseases, Policlinico S. Matteo, University of Pavia (G. Barbarini), Italy.

Correspondence to Dr Giuseppe Barbaro, MD, Viale Anicio Gallo 63, 00174 Rome, Italy.

Background—Increased levels of tumor necrosis factor-{alpha} (TNF-{alpha}) and inducible nitric oxide synthase (iNOS) have been reported in patients with dilated cardiomyopathy. We investigated the myocardial expression of TNF-{alpha} and iNOS in patients with HIV-associated cardiomyopathy (HIV-DCM) compared with patients with idiopathic dilated cardiomyopathy (IDCM).

Methods and Results—Endomyocardial biopsy specimens from 82 HIV-DCM and 80 IDCM patients were processed for determination of the immunostaining intensity of TNF-{alpha} and iNOS and for virological examination. Negative controls were derived from autopsy myocardium specimens from 32 HIV-negative patients without known heart disease. The mortality rate for congestive heart failure between groups according to the intensity of iNOS staining was also evaluated. The mean intensity of both TNF-{alpha} and iNOS staining was greater in patients with HIV-DCM (0.81 and 1.007, respectively) than in patients with IDCM (0.44 and 0.49, respectively) and controls (0.025 and 0.027, respectively). The staining intensity of both TNF-{alpha} and iNOS was inversely correlated with CD4 count. The staining intensity of iNOS was greater in HIV-DCM patients with HIV/coxsackievirus B3 (CVB3) or with HIV/cytomegalovirus coinfection than in IDCM patients showing infection with CVB3 and adenovirus alone. The staining intensity of iNOS correlated to mortality rate, because it was higher in HIV-DCM patients and, in particular, in those with an optical density unit >1.

Conclusions—Cytokine activation seems to play a significant pathogenetic role in both HIV-DCM and IDCM. In HIV-DCM patients, the state of immunodeficiency may favor the selection of viral variants of increased pathogenicity, influencing the clinical course of cardiomyopathy by enhancement of the inflammatory process.


Key Words: AIDS • viruses • cardiomyopathy • hormones • nitric oxide synthase




This article has been cited by other articles:


Home page
CirculationHome page
A. J. Lokuta, N. A. Maertz, S. V. Meethal, K. T. Potter, T. J. Kamp, H. H. Valdivia, and R. A. Haworth
Increased Nitration of Sarcoplasmic Reticulum Ca2+-ATPase in Human Heart Failure
Circulation, March 1, 2005; 111(8): 988 - 995.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. A Chaves, M. J Mihm, B. L Schanbacher, A. Basuray, C. Liu, L. W Ayers, and J. Anthony Bauer
Cardiomyopathy in a murine model of AIDS: evidence of reactive nitrogen species and corroboration in human HIV/AIDS cardiac tissues
Cardiovasc Res, October 15, 2003; 60(1): 108 - 118.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
Y. Chen, G. Davis-Gorman, R. R. Watson, and P. F. McDonagh
ETHANOL MODULATES CORONARY PERMEABILITY TO MACROMOLECULES IN MURINE AIDS
Alcohol Alcohol., November 1, 2002; 37(6): 555 - 560.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Twu, N. Q. Liu, W. Popik, M. Bukrinsky, J. Sayre, J. Roberts, S. Rania, V. Bramhandam, K. P. Roos, W. R. MacLellan, et al.
Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled pathways
PNAS, October 29, 2002; 99(22): 14386 - 14391.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Raidel, C. Haase, N. R. Jansen, R. B. Russ, R. L. Sutliff, L. W. Velsor, B. J. Day, B. D. Hoit, A. M. Samarel, and W. Lewis
Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage
Am J Physiol Heart Circ Physiol, May 1, 2002; 282(5): H1672 - H1678.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Kan, Z. Xie, and M. S. Finkel
HIV gp120 enhances NO production by cardiac myocytes through p38 MAP kinase-mediated NF-kappa B activation
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3138 - H3143.
[Abstract] [Full Text] [PDF]